Roka Bioscience, Inc. (NASDAQ:ROKA) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders
stockholders (the Annual Meeting) on June 28, 2017. At the Annual
Meeting, the Companys stockholders voted on the two proposals
listed below. The proposals are described in detail in the
Companys definitive proxy statement for the Annual Meeting filed
with the Securities and Exchange Commission on May 11, 2017. The
final results for the votes regarding each proposal are set forth
below.
Class III directors to serve a three-year term expiring at the
annual meeting of stockholders to be held in 2020 and until their
successors have been duly elected and qualified. The tabulation
of votes with respect to the election of such Class III directors
was as follows:
|
For
|
Withheld
|
Broker
Non-Votes
|
|
|
Michael P. Doyle
|
2,882,691
|
20,436
|
792,821
|
|
David W.J. McGirr
|
2,882,691
|
20,436
|
792,821
|
|
Nicholas J. Valeriani
|
2,882,691
|
20,436
|
792,821
|
of PricewaterhouseCoopers LLP as the Companys independent
registered public accounting firm for the year ending December
31, 2017. The tabulation of votes with respect to this proposal
was as follows:
|
For
|
Against
|
Abstain
|
Broker
Non-Votes
|
|
3,647,266
|
31,420
|
17,262
|
About Roka Bioscience, Inc. (NASDAQ:ROKA)
Roka Bioscience, Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company offers Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using culture-based assays, immunochemical-based assays and molecular-based assays. The Company sells its Atlas Detection Assays and related consumable supplies for use with its Atlas instruments. The Company’s Atlas instrument is an automated molecular diagnostic testing and a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single, integrated platform.
